↓ Skip to main content

Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers

Overview of attention for article published in Current Pharmaceutical Design, September 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#35 of 3,139)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
2 news outlets
policy
1 policy source
twitter
20 tweeters
facebook
8 Facebook pages
reddit
1 Redditor
video
2 video uploaders

Citations

dimensions_citation
148 Dimensions

Readers on

mendeley
321 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers
Published in
Current Pharmaceutical Design, September 2012
DOI 10.2174/138161212802884780
Pubmed ID
Authors

R. Martin-Santos, J. A. Crippa, A. Batalla, S. Bhattacharyya, Z. Atakan, S. Borgwardt, P. Allen, M. Seal, K. Langohr, M. Farre, AW. Zuardi, P. K. McGuire

Abstract

Animal and humans studies suggest that the two main constituents of cannabis sativa, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) have quite different acute effects. However, to date the two compounds have largely been studied separately.

Twitter Demographics

The data shown below were collected from the profiles of 20 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 321 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 <1%
United States 2 <1%
United Kingdom 1 <1%
Germany 1 <1%
Unknown 315 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 62 19%
Student > Ph. D. Student 47 15%
Student > Master 45 14%
Researcher 35 11%
Other 19 6%
Other 56 17%
Unknown 57 18%
Readers by discipline Count As %
Medicine and Dentistry 60 19%
Neuroscience 34 11%
Psychology 32 10%
Agricultural and Biological Sciences 31 10%
Pharmacology, Toxicology and Pharmaceutical Science 31 10%
Other 59 18%
Unknown 74 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 38. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 August 2020.
All research outputs
#653,672
of 17,360,236 outputs
Outputs from Current Pharmaceutical Design
#35
of 3,139 outputs
Outputs of similar age
#3,915
of 132,921 outputs
Outputs of similar age from Current Pharmaceutical Design
#1
of 36 outputs
Altmetric has tracked 17,360,236 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,139 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 132,921 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.